| The COVID-19 pandemic has affected invasive meningococcal disease (IMD) globally. |
| Recent increases in IMD cases have been observed, most of which were meningococcal serogroup B. |
| Implementation and prioritization of IMD vaccination programs is necessary. |
| Health technology assessments need to consider the full range of meningococcal vaccination benefits. |
| The increasing number of IMD cases highlights the need for preparedness by implementing vaccination programs now instead of reactively. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.